References
- Bauman, P., D. J. Brenner, J. J. Farmer, W. Frederiksen, and J. M. Shewan. 1984. Facultatively anaerobic Gram-negative Rods, pp. 506-513. In N. R. Krieg and J. G. Holt (eds.), Bergey's Manual of Systematic Bacteriology, 9th Ed. Williams and Wilkins, Baltimore/London
- Branca, C., S. Magazu, G. Maisano, P. Migliardo, E. Tettamanti. 1999. On the bioprotectiveness of trehalose: ultrasonic technique, Raman scattering and NMR investigations. J. Mol. Struc. 480-481: 133-140 https://doi.org/10.1016/S0022-2860(98)00626-7
- Carninci, P., Y. Nishiyama, A. Westover, M. Y. Itoh, S. Nagaoka, N. Sasaki, Y. Okazaki, M. Muramatsu, and Y. Hayashizaki. 1998. Thermostabilization and thermoactivation of thermolabile enzymes by trehalose and its application for the synthesis of full length cDNA. Proc. Natl. Acad. Sci. USA. 95: 520-524 https://doi.org/10.1073/pnas.95.2.520
- Clancy, C. J. and M. H. Nguyen. 1997. Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts. J. Clin. Microbiol. 35: 2878-2882
- Cohen, B. E. 1998. Amphotericin B toxicity and lethality: a tale of two channels. Int. J. Pharm. 162: 95-106 https://doi.org/10.1016/S0378-5173(97)00417-1
- Kang, M. J., B. K. Lee, E. W. Lee and K. H. Kim. 2008. Physicochemical properties of an anti-yeast substance produced by Rahnella aquatilis strain AY2000. Kor. J. Microbiol. Biotechnol. 36: 285-290
- Kang, M. J., B. K. Lee, and K. H. Kim. 2008. Characteristics of Rahnella aquatilis strain AY2000 for a anti-yeast substance production. Kor. J. Microbiol. Biotechnol. 36: 215-220
- Kirchgessner, M., DVM. 2008. Therapeutic review amphotericin B. J. Exotic Pet Medicine. 17: 54-56 https://doi.org/10.1053/j.jepm.2007.12.010
- Ryu. E. J., H. W. Kim, B. W. Kim, H. J. Kwon, and K. H. Kim. 2006. Rahnella aquatilis stran AY2000 produces an anti-yeast substance. J. Microbiol. Biotechnol. 10: 1597-1604
- National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 2nd ed. NCCLS document M27-A2, Wayne, PA, USA
- Nguyen, V. K., N. Leulerc, C.-M. Wolff, P. Kennel, P. Fonteneau, R. Deyes, J.-M. Warter, and P. Poindron. 1999. Protechtion of immunoreactivity of dry immobilized proteins on microtitration plates in ELISA: application for detection of autoantibodies in Myasthenia gravis. J. Biotech. 72: 115-125 https://doi.org/10.1016/S0168-1656(99)00099-1
- Menegola, E., M. L. Broccia, F. D. Renzo, and E. Giavini. 2006. Postulated pathogenic pathway in triazole fungicide induced dysmorphogenic effects. Reproid. Toxicol. 22: 186-195 https://doi.org/10.1016/j.reprotox.2006.04.008
- Patton, L. L., DDS, A. J. Bonito, PhD, and D. A. Shugars, DDS, PhD, C. Hill, NC. 2001. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. Oral Surg. Oral Med. Oral Pathol. Radiol. Endod. 92: 170-179 https://doi.org/10.1067/moe.2001.116600